Back to search
Scientific Name: Dacarbazine
Brand Name: Not Available
Company Owner: Abraxis pharmaceutical products, App pharmaceuticals llc, Bedford laboratories div ben venue laboratories inc, Hospira inc, Teva parenteral medicines inc, Bayer healthcare pharmaceuticals inc
Mechanism Of Action The mechanism of action is not known, but appears to exert cytotoxic effects via its action as an alkylating agent. Other theories include DNA synthesis inhibition by its action as a purine analog, and interaction with SH groups. Dacarbazine is not cell cycle-phase specific.
Description of the Drug: Dacarbazine is an antineoplastic agent used to treat malignant melanoma and Hodgkin’s disease.
Protein Data Bank: Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00851